v3.26.3
Revenues (Tables)
9 Months Ended
Sep. 30, 2026
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue
The Company’s revenues disaggregated by geography, based on the destination to which the Company ships its products, for the three and nine months ended September 30, 2026 and 2025 were as follows (in thousands):
Three Months Ended September 30,
Nine Months Ended September 30,
2026
2025
2026
2025
United States
$
324,248 
$
275,029 
$
926,080 
$
792,707 
International
85,897 
79,656 
248,869 
225,573 
Total
$
410,145 
$
354,685 
$
1,174,949 
$
1,018,280 
The Company’s revenues disaggregated by product category for the three and nine months ended September 30, 2026 and 2025 were as follows (in thousands):
Three Months Ended September 30,
Nine Months Ended September 30,
2026
2025
2026
2025
Thrombectomy
$
279,157 
$
236,422 
$
792,055 
$
693,222 
Embolization and Access
130,988 
118,263 
382,894 
325,058 
Total
$
410,145 
$
354,685 
$
1,174,949 
$
1,018,280 
Summary of Contract Assets
The following information summarizes the Company’s contract assets (in thousands):
September 30, 2026
December 31, 2025
Contract assets
$
18,000 
$
18,000